London, United Kingdom, 8th December 2025, FinanceWire … Read More
Stocks
PolyPid Clears a Key FDA Milestone, Reducing Regulatory Risk Ahead of Its Planned NDA Filing (NASDAQ: PYPD)
WSW, NY, 5th December 2025, FinanceWire … Read More
DarioHealth is Gaining Strong Momentum as GLP-1 Costs Reshape Employer Health Strategy (NASDAQ: DRIO)
WSW, NY, 5th December 2025, FinanceWire … Read More
BiomX Is Targeting the Infection Threat Returning to Modern War – And the Military Is Paying Attention (NYSE: PHGE)
WSW, NY, 4th December 2025, FinanceWire … Read More
TrustFinance Announces Winners of the Performance Awards 2025, Recognizing Global Leaders in Finance
Singapore, Singapore, 3rd December 2025, FinanceWire … Read More
KVB Wins “Excellence in Trust & Security” at the TrustFinance Performance Awards 2025
Singapore, Singapore, 3rd December 2025, FinanceWire … Read More
Followme Wins “Top Choice for Social Traders” at the TrustFinance Performance Awards 2025
Singapore, Singapore, 3rd December 2025, FinanceWire … Read More
Silexion Therapeutics Advances Toward a Late-Stage Phase 2/3 Trial in Pancreatic Cancer With Strong Regulatory Momentum (NASDAQ: SLXN)
WSW, NY, 2nd December 2025, FinanceWire … Read More
Entera Bio Is Building More Than a GLP-1 Story – It’s Advancing the First Oral Anabolic for a 200M-Patient Disease (NASDAQ: ENTX)
WSW, NY, 1st December 2025, FinanceWire … Read More
Inspira Technologies Is Building Real Momentum in a Respiratory Support Market Others Have Overlooked (NASDAQ: IINN)
WSW, NY, 1st December 2025, FinanceWire … Read More